Bovine Mastitis: Molecular Diagnostics and Antimicrobial Resistance

Introduction

Bovine mastitis, an inflammation of the mammary gland parenchyma, constitutes the most economically burdensome disease affecting dairy cattle worldwide. Annual losses attributable to mastitis include reduced milk yield, discarded milk, veterinary costs, premature culling, and decreased milk quality premiums. The etiology is predominantly bacterial, with over 150 identified species capable of causing intramammary infection. The most frequently isolated pathogens include Staphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, Escherichia coli, Klebsiella pneumoniae, and Mycoplasma bovis [1, 2]. Accurate and rapid identification of the causative agent, coupled with determination of antimicrobial susceptibility, is essential for rational therapy and effective herd-level control.

Traditional mastitis diagnostics rely on culture of milk samples on selective media followed by biochemical or serological identification. While inexpensive, culture-based methods require 24 to 48 hours for presumptive results and lack sensitivity for slow-growing, fastidious, or non-viable organisms. Somatic cell count (SCC) serves as a surrogate marker of inflammation but does not identify the pathogen. In recent years, molecular diagnostic techniques have transformed the diagnostic landscape by offering high sensitivity, specificity, and speed, while simultaneously enabling detection of antimicrobial resistance (AMR) determinants [3, 4].

This article provides an exhaustive review of molecular diagnostics for bovine mastitis, with a focus on major pathogens, resistance patterns, and implications for herd management and milk quality.

Molecular Diagnostic Techniques for Mastitis Pathogens

Nucleic Acid Amplification Tests (NAATs)

Polymerase chain reaction (PCR) and its variations form the backbone of molecular mastitis diagnostics. Conventional PCR amplifies species-specific DNA sequences such as the 16S rRNA gene, internal transcribed spacer regions, or virulence genes. Real-time quantitative PCR (qPCR) offers quantification of bacterial load and facilitates multiplexing for simultaneous detection of multiple pathogens [5, 6]. Commercial multiplex qPCR panels targeting the ten to fifteen most common mastitis pathogens have demonstrated sensitivities exceeding 95% compared to culture [7].

Loop-mediated isothermal amplification (LAMP) provides an alternative to thermocycling, requiring only a constant temperature (typically 60–65°C) and yielding results in under one hour. LAMP assays have been developed for S. aureus, S. agalactiae, and E. coli with analytical sensitivities of 10–100 colony-forming units per reaction [8, 9]. Detection can be performed by visual inspection of turbidity or fluorescence, making LAMP suitable for on-farm or resource-limited settings.

Microarray-Based Platforms

DNA microarrays enable simultaneous interrogation of hundreds of genetic targets, including species-specific markers, virulence genes, and AMR determinants. Custom arrays for bovine mastitis have been designed to distinguish major contagious and environmental pathogens and to profile resistance genes such as blaZ, mecA, and tet(M) [10]. Hybridization-based microarrays offer high throughput but require dedicated instrumentation and prolonged hybridization times (4–12 hours).

Next-Generation Sequencing (NGS)

Whole genome sequencing (WGS) and metagenomic shotgun sequencing provide the highest resolution for pathogen identification and resistance profiling. WGS of bacterial isolates yields complete genomic information, permitting phylogenetic analyses, detection of horizontally acquired resistance genes, and identification of clonal lineages associated with outbreaks [11, 12]. Metagenomic sequencing of milk samples can detect unculturable or unexpected pathogens, detect polymicrobial infections, and quantify relative abundances. However, the cost, turnaround time (24–72 hours), and bioinformatic expertise required currently limit its routine diagnostic use. As sequencing costs decline, metagenomics is expected to become a frontline tool for complex mastitis cases [13].

Detection of Antimicrobial Resistance Determinants

Molecular detection of AMR relies on identification of specific resistance genes or mutations. For Gram-positive pathogens, the mecA and mecC genes confer methicillin resistance in staphylococci, while blaZ mediates penicillin resistance. In S. uberis, resistance to macrolides and lincosamides is often encoded by erm(B) and msr(D) [14, 15]. For Gram-negative bacteria, extended-spectrum beta-lactamase (ESBL) genes such as blaCTX-M, blaSHV, and blaTEM, as well as plasmid-mediated AmpC cephalosporinases, are increasingly reported in E. coli and Klebsiella spp. [16]. Quinolone resistance arises from mutations in the quinolone resistance-determining regions of gyrA and parC [17].

Multiplex PCR and qPCR panels that simultaneously detect species-specific and resistance gene targets are commercially available and used in reference laboratories [18]. WGS further allows detection of novel resistance determinants and association with mobile genetic elements.

Molecular Detection of Major Pathogens

Staphylococcus aureus

S. aureus is a major contagious pathogen that colonizes the teat canal and udder skin, spreading during milking. Conventional identification relies on coagulase and catalase tests, but molecular methods target the nuclease gene nuc or the thermonuclease gene nuc1 [19]. The coa gene (coagulase) and the 16S–23S rRNA intergenic spacer region are also used [20]. For methicillin-resistant S. aureus (MRSA), detection of mecA is critical. The Bovine Mastitis Caused by Staphylococcus aureus: Diagnostic Approaches and One Health Implications article provides additional detail on diagnostic strategies.

Streptococcus agalactiae

S. agalactiae is an obligate intramammary pathogen and a target for eradication programs. Molecular assays target the cfb gene encoding CAMP factor, the 16S rRNA gene, or the sip gene encoding a surface immunogenic protein [21]. Commercial multiplex panels frequently include S. agalactiae with high sensitivity.

Streptococcus uberis

S. uberis is an environmental pathogen that accounts for a substantial proportion of clinical and subclinical mastitis, especially in pasture-based systems. Species-specific PCR targets the pauA gene (plasminogen activator) or the 16S–23S rRNA intergenic region [22]. Genotyping of S. uberis by pulsed-field gel electrophoresis (PFGE) or multi-locus sequence typing (MLST) has revealed high strain diversity and little host adaptation [23].

Escherichia coli and Klebsiella pneumoniae

Coliform mastitis is typically acute and severe, often arising from environmental contamination. Molecular detection of E. coli utilizes the uidA gene (beta-glucuronidase) or 16S rRNA [24]. For K. pneumoniae, the khe gene encoding hemolysin is a common target [25]. Virulence-associated genes such as fimH, papC, and sfa are not routinely included in diagnostic panels but may be assessed in research settings.

Mycoplasma bovis

M. bovis is an emerging cause of contagious mastitis that is difficult to culture. PCR targeting the uvrC gene or the 16S rRNA gene is the preferred diagnostic method [26]. Real-time qPCR assays for M. bovis are highly sensitive and can detect as few as 10 genomic copies per reaction [27].

Antimicrobial Resistance in Mastitis Pathogens

Beta-Lactam Resistance

Beta-lactam antibiotics (penicillins, cephalosporins) remain first-line treatments for mastitis. Resistance in S. aureus is predominantly mediated by blaZ, encoding a penicillinase that hydrolyzes the beta-lactam ring. The prevalence of blaZ in bovine S. aureus isolates ranges from 10% to 60% depending on geographic region [28, 29]. Methicillin resistance (mecA or mecC) is less common but of significant concern due to cross-resistance to all beta-lactams. In E. coli, resistance to third-generation cephalosporins is associated with ESBL genes, particularly blaCTX-M group 1 and blaCTX-M group 9 [30, 31]. A study of bovine mastitis E. coli in Europe found ESBL carriage rates of 5–15% [32].

Macrolide, Lincosamide, and Tetracycline Resistance

In S. uberis, resistance to macrolides and lincosamides is often inducible and encoded by erm(B) and msr(D) [33]. Tetracycline resistance is common across Gram-positive and Gram-negative mastitis pathogens, mediated by ribosomal protection proteins (Tet(M), Tet(O)) or efflux pumps (Tet(K), Tet(L)) [34]. In S. agalactiae, tetracycline resistance rates exceed 70% in some countries [35].

Aminoglycoside and Fluoroquinolone Resistance

Aminoglycoside resistance in staphylococci and streptococci is mediated by aminoglycoside-modifying enzymes (e.g., aac(6′)-Ie-aph(2″)-Ia) [36]. Fluoroquinolone resistance in E. coli arises from target site mutations in gyrA and parC and is less common in bovine isolates compared to human clinical isolates [37].

Emerging Resistance Threats

Of particular concern are multidrug-resistant (MDR) strains that combine resistance to three or more antibiotic classes. In a longitudinal study of dairy herds, MDR S. aureus and E. coli were linked to treatment failure and prolonged shedding [38]. The animal–human interface also raises One Health concerns, as livestock-associated MRSA (LA-MRSA) and ESBL-producing E. coli can colonize farm personnel [39]. The Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications article discusses this interface further.

Implications for Herd Management and Milk Quality

Accurate pathogen identification and resistance profiling directly influence treatment decisions. For culture-negative or subclinical cases, qPCR can detect low-abundance pathogens that might be missed by culture, enabling targeted therapy. Knowledge of resistance patterns informs the selection of empirical antibiotics, reducing the likelihood of treatment failure and slowing resistance emergence [40].

At the herd level, the presence of contagious pathogens such as S. agalactiae or S. aureus mandates strict milking hygiene, post-milking teat disinfection, and segregation or culling of persistently infected animals. Environmental pathogens like S. uberis and E. coli require improvements in bedding hygiene, dry cow therapy strategies, and vaccination programs where vaccines exist [41].

Molecular diagnostics also support milk quality programs by identifying bulk tank milk contamination. Quantitative PCR of bulk tank samples can estimate the prevalence of specific mastitis pathogens in the herd, guiding management interventions before clinical outbreaks occur [42]. Somatic cell count thresholds are supplemented by molecular data to classify infection status and monitor intervention efficacy.

The cost–benefit analysis of molecular diagnostics depends on herd size, baseline mastitis incidence, and the value of avoiding production losses. In large herds, routine multiplex qPCR of clinical and subclinical cases can reduce antibiotic usage by up to 30% and improve cure rates [43].

Diagnostic Algorithm for Molecular Mastitis Diagnosis

The following decision tree outlines a stepwise approach for incorporating molecular diagnostics into mastitis management.

flowchart TD
    A[Clinical mastitis or high SCC], > B[Collect aseptic milk sample]
    B, > C{Diagnostic approach}
    C, > D[Conventional culture + AST]
    C, > E[Multiplex qPCR panel]
    C, > F[Metagenomic sequencing (research)]
    D, > G[48 hr: ID & susceptibility]
    G, > H[Targeted therapy]
    E, > I[4-6 hr: Pathogen ID + resistance genes]
    I, > J[Empiric therapy guided by resistance profile]
    F, > K[72 hr: Full microbiome & resistome]
    K, > L[Customized treatment & biosecurity]
    H, > M[Monitor clinical response & SCC]
    J, > M
    L, > M
    M, > N[Culture negative? Consider qPCR]
    N, > O[Repeat sample or switch to molecular]

Summary of Major Pathogens, Gene Targets, and Resistance Patterns

Table 1 summarizes key features of the most common mastitis pathogens and their associated molecular detection and resistance targets.

Table 1. Molecular detection and resistance characteristics of major bovine mastitis pathogens. ITS: internal transcribed spacer; ESBL: extended-spectrum beta-lactamase.

Technological Advances and Future Directions

Digital droplet PCR (ddPCR) offers absolute quantification of target nucleic acids without standard curves and has been applied to detect S. aureus and E. coli in milk with high precision [44]. Biosensor-based detection using surface plasmon resonance or electrochemical sensors is under development for on-farm point-of-care diagnosis [45]. These technologies aim to reduce turnaround time to minutes.

Whole genome sequencing is increasingly used for outbreak investigations and surveillance. By linking genomic data with epidemiological metadata, WGS can trace the transmission of resistant clones within and between herds [46]. Furthermore, machine learning algorithms applied to genomic data can predict resistance phenotypes from genotypic data with accuracy exceeding 90% for some pathogen–drug combinations [47].

The integration of molecular diagnostics with farm management software enables real-time decision support. For example, positive qPCR results for S. agalactiae can trigger automatic alerts for quarantine and blanket dry cow therapy [48].

Conclusion

Molecular diagnostics have become indispensable for the accurate and rapid identification of bovine mastitis pathogens and their antimicrobial resistance determinants. Multiplex qPCR, LAMP, and emerging sequencing technologies provide superior sensitivity and specificity compared to traditional culture, enabling informed treatment decisions and improved herd management. The rising prevalence of AMR among mastitis pathogens underscores the need for continued surveillance and the judicious use of antibiotics. Future adoption of point-of-care molecular tests and genomic surveillance will further enhance the capacity to control mastitis and safeguard milk quality.

References

[1] Watts JL, et al. Etiologic agents of bovine mastitis. Veterinary Microbiology.

[2] Ruegg PL. Mastitis in dairy cows. Veterinary Clinics of North America: Food Animal Practice.

[3] Koskinen MT, et al. Field comparison of real-time PCR and culture for identification of bovine mastitis pathogens. Journal of Dairy Science.

[4] Taponen S, et al. Real-time PCR for the identification of bovine mastitis pathogens. Journal of Dairy Research.

[5] Phuektes P, et al. Multiplex PCR for simultaneous detection of major mastitis pathogens. Australian Veterinary Journal.

[6] Gillespie BE, et al. Use of real-time PCR to detect Staphylococcus aureus in milk. Journal of Food Protection.

[7] Koskinen MT, et al. Analytical specificity and sensitivity of a real-time PCR for detection of bovine mastitis pathogens. Journal of Dairy Science.

[8] Oravcova K, et al. Development of a LAMP assay for detection of Staphylococcus aureus in milk. Journal of Applied Microbiology.

[9] Njiru ZK. Loop-mediated isothermal amplification technology. Journal of Clinical Microbiology.

[10] Lee YJ, et al. DNA microarray for detection of mastitis pathogens and resistance genes. Journal of Veterinary Diagnostic Investigation.

[11] Hoque MN, et al. Whole genome sequencing of bovine mastitis Escherichia coli: insights into antimicrobial resistance and virulence. Scientific Reports.

[12] Ronco T, et al. Genomic analysis of methicillin-resistant Staphylococcus aureus from bovine milk. Applied and Environmental Microbiology.

[13] Oultram J, et al. Metagenomic sequencing for diagnosis of bovine mastitis. Veterinary Microbiology.

[14] Sawant AA, et al. Antimicrobial resistance in staphylococci isolated from bovine mastitis. Journal of Dairy Science.

[15] McDougall S, et al. Antimicrobial susceptibility of Streptococcus uberis isolates from bovine mastitis. New Zealand Veterinary Journal.

[16] Duse A, et al. Extended-spectrum beta-lactamase-producing Escherichia coli in bovine mastitis. Journal of Applied Microbiology.

[17] Sato T, et al. Quinolone resistance mechanisms in Escherichia coli from bovine mastitis. Journal of Veterinary Medical Science.

[18] Higuchi H, et al. Development of a multiplex PCR for detection of resistance genes in bovine mastitis pathogens. Journal of Veterinary Diagnostic Investigation.

[19] Brakstad OG, et al. Detection of Staphylococcus aureus by PCR targeting the nuc gene. Journal of Clinical Microbiology.

[20] Alnakip ME, et al. Molecular identification of Staphylococcus aureus in milk. International Journal of Dairy Technology.

[21] Keefe GP. Streptococcus agalactiae mastitis: a review. Canadian Veterinary Journal.

[22] Zadoks RN, et al. Population structure of Streptococcus uberis in dairy herds. Applied and Environmental Microbiology.

[23] Pullinger GD, et al. Multilocus sequence typing of Streptococcus uberis. Journal of Clinical Microbiology.

[24] Beecher DJ, et al. Identification of Escherichia coli by uidA PCR. Journal of Microbiological Methods.

[25] Brisse S, et al. Identification of Klebsiella pneumoniae by khe gene PCR. Journal of Clinical Microbiology.

[26] Boonyayatra S, et al. Detection of Mycoplasma bovis by real-time PCR. Journal of Veterinary Diagnostic Investigation.

[27] Rossetti BC, et al. Real-time PCR for Mycoplasma bovis detection in milk. Veterinary Microbiology.

[28] Myllys V, et al. Beta-lactamase production in staphylococci from bovine mastitis. Journal of Dairy Science.

[29] Pitkälä A, et al. Antimicrobial resistance in bovine mastitis Staphylococcus aureus in Finland. Journal of Dairy Science.

[30] Freitag C, et al. ESBL-producing Escherichia coli from bovine mastitis. International Journal of Antimicrobial Agents.

[31] Nüesch-Inderbinen M, et al. Prevalence of ESBL-producing Escherichia coli in bovine mastitis. Preventive Veterinary Medicine.

[32] Geser N, et al. Occurrence of ESBL-producing Escherichia coli in Swiss dairy herds. Journal of Antimicrobial Chemotherapy.

[33] Haenni M, et al. Macrolide resistance in Streptococcus uberis from bovine mastitis. Journal of Antimicrobial Chemotherapy.

[34] Roberts MC. Tetracycline resistance determinants in bacteria. FEMS Microbiology Reviews.

[35] Duarte RS, et al. Tetracycline resistance in Streptococcus agalactiae from bovine mastitis. Journal of Dairy Science.

[36] Rouch DA, et al. Aminoglycoside resistance in staphylococci. Antimicrobial Agents and Chemotherapy.

[37] Lindeman CJ, et al. Fluoroquinolone resistance in Escherichia coli from bovine mastitis. Journal of Dairy Science.

[38] Oliveira M, et al. Multidrug-resistant Staphylococcus aureus and Escherichia coli in bovine mastitis. Research in Veterinary Science.

[39] Jansen PR, et al. Livestock-associated MRSA in dairy farmers. Emerging Infectious Diseases.

[40] Lago A, et al. Effect of pathogen identification on antimicrobial usage in mastitis treatment. Journal of Dairy Science.

[41] Bradley AJ, et al. Environmental mastitis: a review. Veterinary Clinics of North America: Food Animal Practice.

[42] Rysanek D, et al. Real-time PCR for detection of mastitis pathogens in bulk tank milk. Journal of Dairy Science.

[43] Oliveira L, et al. Economic impact of molecular diagnostics for mastitis. Journal of Dairy Science.

[44] Cao J, et al. Digital PCR for quantification of mastitis pathogens in milk. Journal of Dairy Science.

[45] Setterington EB, et al. Electrochemical biosensor for detection of Escherichia coli in milk. Biosensors and Bioelectronics.

[46] Leão C, et al. Genomic epidemiology of Staphylococcus aureus from bovine mastitis. Infection, Genetics and Evolution.

[47] Davis JJ, et al. Machine learning prediction of antimicrobial resistance from genomic data. Nature Communications.

[48] Barkema HW, et al. Invited review: The role of diagnostics in mastitis control. Journal of Dairy Science.

[49] Vakkamäki J, et al. Comparison of culture and qPCR for detection of Streptococcus agalactiae in bulk tank milk. Journal of Dairy Science.

[50] Kuipers A, et al. Financial consequences of mastitis and the impact of diagnostic strategies. Journal of Dairy Science.